Research Projects
Exploiting the VULNErabilities generated by the pharmacological inhibition of kRAS for the development of combined therapeutic strategies
Researcher | Principal Investigator
Oncogenes and Effector Targets Research Group
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Oncogenes and Effector Targets
Project information
“Exploiting the vulnerabilities generated by pharmacological inhibition of kRAS for the development of combination therapy strategies” is a project by the Oncogenes and Effector Targets research group, part of the Solid Tumors research program.
Project PID2023-152755OB-I00 funded by:
- Convocation: Proyectos de Generación de Conocimiento 2023
- Reference: PID2023-152755OB-I00
- Start date: September 1, 2024
- End date: August 31, 2027
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.